15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Stride Inc, 2 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $95.00 to $125.00, so the covering firms are broadly aligned. The average target of $113.25 sits 18% above the current $95.88. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.50 next quarter toward $8.76 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy250%
Hold250%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Stride Inc.
As of Jul, 2 of 4 firms rate LRN a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
LRN EPS & revenue forecast
EPS · NEXT QUARTER
$1.50
Range $1.50 – $1.50 · 1 analysts · -1% YoY
Next period, 1 analysts expect Stride Inc to earn $1.50 a share (range $1.50 – $1.50), versus $1.52 a year earlier. , growing to $8.76 the year after.
REVENUE · NEXT QUARTER
$642.8M
Range $637.0M – $648.5M · 1 analysts · +4% YoY
Revenue is expected to reach $642.8M (range $637.0M – $648.5M), +3.5% year-over-year., rising to $2.6B next year.
Top analysts covering Stride Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LRN.
#1
Alexander Paris
Barrington Research · Rank #56
Buy
$125.00+30.4% to target
Overall win rate
54%
+ Follow
#2
Jeffrey Silber
BMO Capital · Rank #269
Hold
$108.00+12.6% to target
Overall win rate
31%
+ Follow
#3
Jason Tilchen
Canaccord Genuity
Buy
$125.00+30.4% to target
Coverage
—
+ Follow
#4
GP
Greg Parrish
Morgan Stanley
Hold
$95.00-0.9% to target
Coverage
—
+ Follow
#5
TS
Thomas Singlehurst
Citigroup
Hold
$94.00-2.0% to target
Coverage
—
+ Follow
LRN stock forecast FAQ
What is LRN's average 12-month price target?+
The 4 analysts with a live target average $113.25 for Stride Inc over the next 12 months, ranging from a $125.00 high to a $95.00 low.
Is LRN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 2 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for LRN?+
The Street-high target is $125.00 (Barrington Research), and the Street-low is $95.00 (Morgan Stanley). The average of all 4 active targets is $113.25.
How many Wall Street analysts cover LRN?+
4 analysts have an active rating on Stride Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering LRN?+
Among analysts who currently cover LRN, Alexander Paris of Barrington Research has the strongest overall Quantellect track record (Rank #56). Their current call is Buy with a $125.00 target.
What is Stride Inc's projected EPS for next quarter?+
The consensus estimate is $1.50 per share (range $1.50 – $1.50) across 1 analysts, rising to $8.76 the following year.
How much revenue is Stride Inc expected to report next quarter?+
Consensus revenue is $642.8M (range $637.0M – $648.5M), growing to $2.6B next year.
Have analysts been upgrading or downgrading LRN lately?+
As of Jul, 2 of 4 firms rate LRN a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LRN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
